Description
UNIT DOSE RADIOPHARMACEUTICALS: DASH 8 EXTENSION
Base award description: UNIT DOSE RADIOPHARMACEUTICALS
Modification chain · 12 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-08-27+$233,164= $233,164
- Mod P000012015-05-19+$320,140= $553,304
- Mod P000022015-07-15+$71,000= $624,304
- Mod P000052015-10-05-$11,074= $613,230
- Mod P000062016-04-11+$329,745= $942,975
- Mod P000082017-05-31+$339,637= $1,282,612
- Mod P000102018-04-18-$10,506= $1,272,106
- Mod P000112018-04-18-$46,053= $1,226,053
- Mod P000122018-05-15+$349,826= $1,575,879
- Mod P000132019-05-13+$175,000= $1,750,879
- Mod P000142019-10-11-$16,980= $1,733,899
- Mod P000152020-12-30-$145,192= $1,588,707
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-08-27 | +$233,164 | $233,164 | UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2015-05-19 | +$320,140 | $553,304 | UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00002· CHANGE ORDER | 2015-07-15 | +$71,000 | $624,304 | UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2015-10-05 | −$11,074 | $613,230 | UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00006· EXERCISE AN OPTION | 2016-04-11 | +$329,745 | $942,975 | UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00008· EXERCISE AN OPTION | 2017-05-31 | +$339,637 | $1,282,612 | UNIT DOSE RADIOPHARMACEUTICALS |
| Mod P00010· FUNDING ONLY ACTION | 2018-04-18 | −$10,506 | $1,272,106 | UNIT DOSE RADIOPHARMACEUTICALS: DEOBLIGATE FY15 FUNDS |
| Mod P00011· FUNDING ONLY ACTION | 2018-04-18 | −$46,053 | $1,226,053 | UNIT DOSE RADIOPHARMACEUTICALS: DE-OBLIGATE FY16 FUNDS |
| Mod P00012· EXERCISE AN OPTION | 2018-05-15 | +$349,826 | $1,575,879 | UNIT DOSE RADIOPHARMACEUTICALS: EXERCISE OY4 |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2019-05-13 | +$175,000 | $1,750,879 | UNIT DOSE RADIOPHARMACEUTICALS: DASH 8 EXTENSION |
| Mod P00014· FUNDING ONLY ACTION | 2019-10-11 | −$16,980 | $1,733,899 | UNIT DOSE RADIOPHARMACEUTICALS: DASH 8 EXTENSION |
| Mod P00015· FUNDING ONLY ACTION | 2020-12-30 | −$145,192 | $1,588,707 | UNIT DOSE RADIOPHARMACEUTICALS: DASH 8 EXTENSION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZKN3LZ6VP556)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926P0396 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $64,984 | FY2026 |
| 36C24826F0140 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $36,838 | FY2026 |
| 36C25026N0497 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $27,788 | FY2026 |
| 36C25026A0036 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26126N0328 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $219,980 | FY2026 |
| 36C24826P0383 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $73,678 | FY2026 |
Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26026F0379 | COSETTE PHARMACEUTICALS, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $3,466 | FY2026 |
| 36C26026P0671 | MCKESSON PLASMA AND BIOLOGICS LLC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $18,262 | FY2026 |
| 36C26026F0349 | AGIOS PHARMACEUTICALS, INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $73,080 | FY2026 |
| 36C26026F0306 | BRACCO DIAGNOSTICS INC. | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $337,422 | FY2026 |
| 36C26026F0298 | PROGENICS PHARMACEUTICALS INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $469,134 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26014P2994_3600_-NONE-_-NONE- · retrieved 2026-09-26.